Figure 2.
The associations between antibiotic use and overall survival (a) and progression-free survival (b) in cancer patients treated with immune checkpoint inhibitors.
The associations between antibiotic use and overall survival (a) and progression-free survival (b) in cancer patients treated with immune checkpoint inhibitors.